Enzo Biochem Inc (ENZ.N)
ENZ.N on New York Stock Exchange
2.29USD
18 Jun 2013
2.29USD
18 Jun 2013
Price Change (% chg)
$0.09 (+4.09%)
$0.09 (+4.09%)
Prev Close
$2.20
$2.20
Open
$2.21
$2.21
Day's High
$2.29
$2.29
Day's Low
$2.19
$2.19
Volume
15,055
15,055
Avg. Vol
20,907
20,907
52-wk High
$3.14
$3.14
52-wk Low
$1.33
$1.33
ENZ.N
About
Enzo Biochem, Inc. (Enzo), is an integrated life sciences and biotechnology company. Enzo has three segments: Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics. Enzo focused on harnessing biological processes to develop research tools, diagnostics and therapeutics and serves as a provider of test services, including... (more)
No analyst recommendations are available for ENZ.N.
Overall
| Beta: | 1.85 |
| Market Cap (Mil.): | $87.87 |
| Shares Outstanding (Mil.): | 39.94 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
Competitors
| Price | Change | |
|---|---|---|
| Quest Diagnostics Inc (DGX.N) | $62.39 | -0.20 |
| Laboratory Corp. of America Holdings (LH.N) | $100.78 | +0.34 |
| Ventas, Inc. (VTR.N) | $71.67 | +0.27 |
| HCP, Inc. (HCP.N) | $45.98 | +0.21 |
| HCP, Inc. (HCP_pf.N) | -- | -- |
| HCP, Inc. (HCP_pe.N) | -- | -- |
| Bio-Reference Laboratories Inc (BRLI.OQ) | $28.61 | -0.32 |
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
